October 31, 2014 5:50 AM ET

Biotechnology

Company Overview of Ataxion, Inc.

Company Overview

Ataxion, Inc. operates as a biotechnology company that develops small-molecule ion-channel modulators for the treatment of hereditary ataxias and other neurological conditions. The company is based in Cambridge, Massachusetts.

25 First Street

Suite 303

Cambridge, MA 02141

United States

Key Executives for Ataxion, Inc.

Founder and Chief Executive Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Ataxion, Inc. Key Developments

Ataxion Announces Board Appointments

Ataxion announced that Holtzman and Kevin Koch will join the board. Resnick, Jean-Francois Formela and David Grayzel of Atlas, and Claus Braestrup, former CEO of Lundbeck Pharmaceuticals and Chairman of Saniona, are also on the company's board of directors.

Similar Private Companies By Industry

Company Name Region
Mystic Pharmaceuticals, Inc. United States
Locus Development Inc. United States
Ganeden Biotech, Inc. United States
GenMetrics United States
Civitas Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 17, 2014
--
Merger/Acquisition
March 17, 2014
Aniona ApS, Ataxia Program
Private Placement
December 17, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ataxion, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.